Before you sell to, join or invest in Bariendo Inc.
MentionFox check on Bariendo Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/bariendo-inc-form-d-25000001
Check Bariendo Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Bariendo Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Bariendo Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-03.
Bariendo Inc. filed a Form D notice of an exempt securities offering with the SEC on April 3, 2025. The filing reports $11.10M sold. Its industry group is Biotechnology. It names Pichayut Jirapinyo (Executive Officer, Director), Pichamol Jirapinyo (Director), Christopher Thompson (Director) (SEC Form D, April 3, 2025).
Is this your company?
Sell to companies like Bariendo Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-03 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Bariendo Inc.
Free to see. No signup.
More on the people and the money behind Bariendo Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in April 2025, largest first.
Get an email when Bariendo Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Bariendo Inc. raises, hires or launches. No email unless you switch it on.
Watch Bariendo Inc. →Get the full cited report on Bariendo Inc.
What the filing shows about Bariendo Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Bariendo Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Bariendo Inc.'s address as 945 Market Street, Suite 501, San Francisco, CA 94103.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Bariendo Inc. is a registered filer with the SEC (CIK 2054636) and has filed since 2025-04-03. 1 filing is on record, the latest on 2025-04-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Bariendo Inc.'s Form D of 2025-04-03 names Pichayut Jirapinyo, Pichamol Jirapinyo, Christopher Thompson and 2 more as its officers, directors or promoters.
Its new offerings report $11.10M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Pichayut Jirapinyo is named as Executive Officer and Director on the Form D that Bariendo Inc. filed with the SEC on 3 April 2025, one of 5 people that filing names.
Pichamol Jirapinyo is named as Director on the Form D that Bariendo Inc. filed with the SEC on 3 April 2025, one of 5 people that filing names.
Christopher Thompson is named as Director on the Form D that Bariendo Inc. filed with the SEC on 3 April 2025, one of 5 people that filing names.
Supachai Parchariyanon is named as Director on the Form D that Bariendo Inc. filed with the SEC on 3 April 2025, one of 5 people that filing names.
Hayden Williams is named as Director on the Form D that Bariendo Inc. filed with the SEC on 3 April 2025, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2025-04-03 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Bariendo Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Bariendo Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bariendo Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Bariendo Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Bariendo Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Bariendo Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/bariendo-inc-form-d-25000001